NCT00941031 - AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis | Biotech Hunter

Enrollment

404

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Chronic Plaque-type Psoriasis

Interventions

DRUG

AIN457

DRUG

AIN457A

"Induction with monthly injections - Monthly: secukinumab (AIN457) 150 mg s.c. administered at weeks 1, 5, 9"

DRUG

AIN457A

"Early loading induction - Early: secukinumab (AIN457) 150 mg s.c. administered at weeks 1, 2, 3, 5"

DRUG

Placebo

"Placebo - Placebo: Placebo administered at weeks 1, 2, 3, 5, 9"

Trial Locations (62)

201

Novartis Investigative Site, Kopavogur

6017

Novartis Investigative Site, Ålesund

10029

Novartis Investigative Site, New York

10117

Novartis Investigative Site, Berlin

14623

Novartis Investigative Site, Rochester

18101

Novartis Investigative Site, Afula

19104

Novartis Investigative Site, Philadelphia

20354

Novartis Investigative Site, Hamburg

22911

Novartis Investigative Site, Charlottesville

23538

Novartis Investigative Site, Lübeck

24105

Novartis Investigative Site, Kiel

24501

Novartis Investigative Site, Lynchburg

27262

Novartis Investigative Site, High Point

30078

Novartis Investigative Site, Snellville

30263

Novartis Investigative Site, Newnan

30625

Novartis Investigative Site, Hanover

31059

Novartis Investigative Site, Toulouse

35233

Novartis Investigative Site, Birmingham

37075

Novartis Investigative Site, Göttingen

40217

Novartis Investigative Site, Louisville

47713

Novartis Investigative Site, Evansville

48038

Novartis Investigative Site, Clinton Twp.

48149

Novartis Investigative Site, Münster

48202

Novartis Investigative Site, Detroit

49100

Novartis Investigative Site, Petah Tikva

52621

Novartis Investigative Site, Ramat Gan

53105

Novartis Investigative Site, Bonn

55131

Novartis Investigative Site, Mainz

55455

Novartis Investigative Site, Minneapolis

60590

Novartis Investigative Site, Frankfurt

61820

Novartis Investigative Site, Champaign

62703

Novartis Investigative Site, Springfield

63117

Novartis Investigative Site, St Louis

66606

Novartis Investigative Site, Topeka

68131

Novartis Investigative Site, Omaha

68144

Novartis Investigative Site, Omaha

72076

Novartis Investigative Site, Tübingen

72205

Novartis Investigative Site, Little Rock

75204

Novartis Investigative Site, Dallas

78759

Novartis Investigative Site, Austin

89052

Novartis Investigative Site, Henderson

91054

Novartis Investigative Site, Erlangen

91105

Novartis Investigative Site, Pasadena

92123

Novartis Investigative Site, San Diego

97035

Novartis Investigative Site, Lake Oswego

97210

Novartis Investigative Site, Portland

02111

Novartis Investigative Site, Boston

06202

Novartis Investigative Site, Nice

01307

Novartis Investigative Site, Dresden

04103

Novartis Investigative Site, Leipzig

467-8602

Novartis Investigative Site, Nagoya

814-0180

Novartis Investigative Site, Fukuoka

807-8556

Novartis Investigative Site, Kitakyushu

830-0011

Novartis Investigative Site, Kurume

371-8511

Novartis Investigative Site, Maebashi

066-0021

Novartis Investigative Site, Chitose

113-8655

Novartis Investigative Site, Bunkyo-ku

173-8610

Novartis Investigative Site, Itabashi-ku

105-8471

Novartis Investigative Site, Minato-ku

141-8625

Novartis Investigative Site, Shinagawa-ku

NO-5021

Novartis Investigative Site, Bergen

0424

Novartis Investigative Site, Oslo